Clinical and category context
Guidelines, treatment pathways, product formats, ingredients, and claims.
Home / Patient & Caregiver Research / Case Study
Anonymized Case Study · Women's Health
Finding a clearer position in a crowded PCOS supplement market.
We connected market structure, competitor claims, search behavior, public audience signals, and product reviews to identify where a new inositol supplement could compete credibly.
Map the categoryProducts, claims, formats
Observe demandSearches and conversations
Understand decisionsProfiles and reviews
Define the positionGaps and recommendations
The challenge
The category was active. The position was not yet clear.
The client was evaluating an inositol supplement for women managing polycystic ovary syndrome. Competitors used overlapping ingredients but told very different stories: some led with PCOS, others with fertility and hormonal balance, and others avoided women's health entirely.
The work needed to distinguish market noise from a defensible opportunity and show what patients were actually trying to understand before choosing a product.
Where could a new product create a credible, useful position without making promises the evidence could not support?
Research design
From category evidence to patient context.
No single source could answer the question. The analysis triangulated market, behavioral, and experiential evidence.
Competitive intelligence
Products, pricing, reviews, positioning, landing pages, and paid communication.
Search intelligence
Topics, related questions, rising terms, brands, and product forms.
Audience profiling
Demographics, interests, affinities, media habits, and public self-description.
Review analysis
Reported benefits, expectations, usage uncertainty, and adverse experiences.
Persona synthesis
Patient needs, life stage, motivations, information gaps, and decision barriers.
Competitive positioning
The same ingredient was competing in three different markets.
Competitors did not simply differ by formulation. They framed the job of the product differently, changing the audience, promise, and burden of proof.
Condition specificityBroader audience →
PCOS-firstSpecific condition and education
Women's healthFertility and hormone balance
General wellnessMood, sleep and metabolism
Conceptual positioning map derived from competitor language and product framing. Placement is directional, not a market-share measure.
PCOS-first
The condition anchors the brand story and product explanation.
- Direct relevance
- High education requirement
- Greater claim sensitivity
Women's health
The product is positioned around ovarian support, fertility, or hormone balance.
- Broader audience
- Softer condition language
- Lower differentiation
General wellness
Inositol is framed around mood, sleep, metabolism, or cellular health.
- Wider use cases
- Less PCOS relevance
- More indirect competition
Search behavior
Patients searched for outcomes, not ingredient science alone.
Search patterns connected PCOS to blood sugar, weight, menstrual regularity, fertility, hair changes, and related conditions. Product education therefore needed to begin with the problem people were trying to solve.
+80%
growth in searches for “spearmint”
A signal of increasing interest in natural approaches. It does not establish clinical effectiveness, but it shows the language and alternatives patients were exploring.
PCOS
search intent
search intent
Symptoms
periods · hair · weight
periods · hair · weight
Fertility
ovulation · egg quality
ovulation · egg quality
Product choice
ratio · dosage · format
Theme groupings, not relative search volumeratio · dosage · format
Public audience analysis
The conversation was concentrated among younger women.
Public social profiles helped describe who was participating in PCOS and inositol conversations and which life-stage questions were most salient.
Gender distribution
Women 88%
Men 11%
Unspecified 1%
Age distribution
Source: public digital audience dataset used in the study. Profiles may include patients, advocates, professionals, and other participants in the conversation.
Patient profiles
The opportunity changed with life stage.
Two priority profiles made the audience evidence operational. They were not stereotypes; they summarized recurring needs and decisions in the data.
01 · RecognizeConnect symptoms to PCOS
02 · ExploreSearch for manageable options
03 · ValidateCompare evidence and reviews
04 · DecideChoose formulation and routine
Profile 0118–24
The symptom manager
Recently diagnosed and looking for practical ways to manage energy, cravings, hair changes, and menstrual irregularity.
- Needs
- Plain-language product education and realistic expectations.
- Barrier
- Uncertainty about formulation, dosage, and time to benefit.
- Decision
- Whether an inositol blend is relevant to her specific symptoms.
Profile 0225–34
The fertility planner
Managing PCOS in the context of weight, menstrual regularity, ovulation, and efforts to conceive.
- Needs
- Evidence, clinician guidance, and information about combined use.
- Barrier
- Skepticism toward paid reviews and generalized wellness claims.
- Decision
- Whether the product fits a broader fertility and metabolic plan.
Product review analysis
Positive outcomes coexisted with basic unanswered questions.
Reviews showed enthusiasm, but they also exposed confusion that could undermine trust and appropriate product use.
Reported benefits
- Reduced cravings and support with weight management
- More regular menstrual cycles
- Improved mood, energy, and sleep
- Reduced hair loss for some users
- Support during efforts to conceive
Reported concerns
- No noticeable improvement in PCOS symptoms
- Confusion about dosage and ingredient ratios
- Expectation that a supplement would “cure” a chronic condition
- Gastrointestinal, mood, sleep, and sexual-health complaints
- Difficulty separating product effects from other conditions or medications
Market gaps
The strongest opportunity was better guidance, not a louder promise.
Own the education gap
Explain formulations, dosage, evidence, expectations, and limitations in plain language.
Build clinical credibility
Use healthcare professional participation to make education more trustworthy and responsible.
Design for chronic management
Frame the product as one component of ongoing PCOS management, not a standalone cure.
Match format to behavior
Prioritize familiar formats such as capsules and powder, with clear instructions and comparison.
Strategic implication
Compete on clarity, credibility, and condition-specific support.
The analysis pointed toward a PCOS-relevant position grounded in education and realistic expectations. The product could be specific enough to feel useful without overpromising treatment outcomes.
Evidence standard
What this study can and cannot establish.
The study identifies market patterns, audience needs, competitive choices, and communication opportunities. Public conversations and reviews are behavioral evidence, but they are not clinical evidence and cannot establish product efficacy or causality.
Recommendations should be reviewed against current clinical, regulatory, and legal requirements before launch.